JP2016514686A5 - - Google Patents

Download PDF

Info

Publication number
JP2016514686A5
JP2016514686A5 JP2016503003A JP2016503003A JP2016514686A5 JP 2016514686 A5 JP2016514686 A5 JP 2016514686A5 JP 2016503003 A JP2016503003 A JP 2016503003A JP 2016503003 A JP2016503003 A JP 2016503003A JP 2016514686 A5 JP2016514686 A5 JP 2016514686A5
Authority
JP
Japan
Prior art keywords
weight
matrix
dosage form
wax
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016503003A
Other languages
English (en)
Japanese (ja)
Other versions
JP6466399B2 (ja
JP2016514686A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/029168 external-priority patent/WO2014144661A1/en
Publication of JP2016514686A publication Critical patent/JP2016514686A/ja
Publication of JP2016514686A5 publication Critical patent/JP2016514686A5/ja
Application granted granted Critical
Publication of JP6466399B2 publication Critical patent/JP6466399B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016503003A 2013-03-15 2014-03-14 トピラマートの急速分散性の剤形 Active JP6466399B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361791592P 2013-03-15 2013-03-15
US61/791,592 2013-03-15
PCT/US2014/029168 WO2014144661A1 (en) 2013-03-15 2014-03-14 Rapidly dispersible dosage form of topiramate

Publications (3)

Publication Number Publication Date
JP2016514686A JP2016514686A (ja) 2016-05-23
JP2016514686A5 true JP2016514686A5 (OSRAM) 2017-04-06
JP6466399B2 JP6466399B2 (ja) 2019-02-06

Family

ID=51537752

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016503003A Active JP6466399B2 (ja) 2013-03-15 2014-03-14 トピラマートの急速分散性の剤形

Country Status (10)

Country Link
US (2) US9492380B2 (OSRAM)
EP (1) EP2968181B1 (OSRAM)
JP (1) JP6466399B2 (OSRAM)
CN (1) CN105050588B (OSRAM)
AU (2) AU2014228861B2 (OSRAM)
CA (1) CA2906172C (OSRAM)
ES (1) ES2761407T3 (OSRAM)
HK (1) HK1213473A1 (OSRAM)
MX (1) MX365914B (OSRAM)
WO (1) WO2014144661A1 (OSRAM)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105534936B (zh) * 2007-08-13 2020-07-31 Ohemo 生命科学股份有限公司 抗滥用药物、使用方法和制备方法
EP3431141B1 (en) 2013-03-15 2021-12-08 Aprecia Pharmaceuticals LLC Three-dimensional printing method
US9339489B2 (en) 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
CN104586871B (zh) * 2014-12-27 2018-01-16 北京罗诺强施医药技术研发中心有限公司 包含托吡酯的药物组合物
US20160243036A1 (en) * 2015-02-25 2016-08-25 Intelgenx Corp. Film dosage forms containing amorphous active agents
WO2016192680A1 (en) 2015-06-03 2016-12-08 Triastek, Inc. Dosage forms and use thereof
ES2992002T3 (es) * 2016-04-06 2024-12-05 Astellas Pharma Inc Moldeo tridimensional de elución rápida, filamento para moldeo tridimensional de elución rápida y material para moldeo tridimensional de elución rápida
WO2018041312A1 (en) 2016-09-02 2018-03-08 Novo Futura Ivs Disposable grill and method of manufacturing a disposable grill
EP3573602A4 (en) 2017-01-26 2020-09-16 Triastek, Inc. DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES
CN107213126B (zh) * 2017-05-17 2020-06-23 西安棣加生物科技有限公司 一种3d打印技术制备治疗高磷血症的口腔速崩片的方法
CN107252418B (zh) * 2017-05-17 2020-06-23 西安棣加生物科技有限公司 一种3d打印技术制备治疗低钾血症的口腔速崩片的方法
US10703549B2 (en) 2017-06-30 2020-07-07 The Procter And Gamble Company Water soluble containers and methods of making them
MX2020004403A (es) * 2017-11-02 2020-08-06 Zambon Spa Composiciones farmaceuticas que comprenden safinamida.
JP7360949B2 (ja) * 2017-12-26 2023-10-13 東和薬品株式会社 環状口腔内崩壊錠
WO2019137200A1 (en) 2018-01-09 2019-07-18 Triastek, Inc. Oral drug dosage forms comprising a fixed-dose of an adhd non-stimulant and an adhd stimulant
CA3096124A1 (en) 2018-04-10 2019-10-17 Panacea Biomatx, Inc. Method and system for making personalized nutritional and pharmaceutical formulations using additive manufacturing
CA3112618A1 (en) * 2018-09-14 2020-03-19 Merck Patent Gmbh Process for the preparation of a coated solid pharmaceutical dosage form
CN112867482B (zh) 2018-10-15 2023-04-25 阿普雷奇亚制药有限责任公司 在包装内形成剂型的方法和系统
US12419857B2 (en) * 2018-11-21 2025-09-23 Rosemont Pharmaceuticals Limited Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
HUE064472T2 (hu) 2019-02-22 2024-03-28 Catalent Uk Swindon Zydis Ltd Agglomeráció, aeráció minimalizálása, és ibuprofent tartalmazó gyógyszerészeti készítmények bevonatának védelme
CN113507923B (zh) 2019-02-22 2024-03-26 康特伦英国斯温顿捷迪斯有限公司 在线混合期间混悬液的曝气最小化
PL3927314T3 (pl) 2019-02-22 2024-02-19 Catalent U.K. Swindon Zydis Limited Minimalizacja aglomeracji materiału powlekającego cząstki leku podczas przechowywania dla ustabilizowania czasów rozpadu produktów farmaceutycznych
AR118159A1 (es) 2019-02-22 2021-09-22 Catalent Uk Swindon Zydis Ltd Minimización de aglomeración, aireación y conservación del revestimiento de composiciones farmacéuticas que comprenden ibuprofeno
US20220408745A1 (en) * 2019-09-13 2022-12-29 Meiji Co., Ltd. Solid food and solid milk having hole penetrating first face and second face
MX2022016117A (es) 2020-06-26 2023-04-05 Aprecia Pharmaceuticals LLC Tabletas rapidamente orodispersables que tienen una cavidad interior.
CA3189404A1 (en) 2020-07-31 2022-02-03 Catalent U.K. Swindon Zydis Limited Pharmaceutical compositions comprising coated api
WO2024108082A1 (en) 2022-11-18 2024-05-23 Aprecia Pharmaceuticals LLC Orodispersive dosage forms containing droxidopa

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4513006A (en) 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US4642903A (en) 1985-03-26 1987-02-17 R. P. Scherer Corporation Freeze-dried foam dosage form
US4855326A (en) 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
EP0418596A3 (en) 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5578322A (en) 1990-11-30 1996-11-26 Yamanouchi Pharmaceutical Co., Ltd. Quick release coated preparation
DE4200821A1 (de) 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
US5518730A (en) 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
US5380473A (en) 1992-10-23 1995-01-10 Fuisz Technologies Ltd. Process for making shearform matrix
US5631023A (en) 1993-07-09 1997-05-20 R.P. Scherer Corporation Method for making freeze dried drug dosage forms
US5490962A (en) * 1993-10-18 1996-02-13 Massachusetts Institute Of Technology Preparation of medical devices by solid free-form fabrication methods
US5738875A (en) 1994-10-28 1998-04-14 R.P. Scherer Corporation Process for preparing solid pharmaceutical dosage forms
US5607697A (en) 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
ATE421318T1 (de) 1997-02-20 2009-02-15 Massachusetts Inst Technology Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
FR2766089B1 (fr) 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
EP1194153B1 (en) 1999-07-09 2004-05-06 Ortho-McNeil Pharmaceutical, Inc. Taste masked pharmaceutical liquid formulations
AU5060499A (en) * 1999-08-04 2001-03-05 Ranbaxy Laboratories Limited Hydrodynamically balanced oral drug delivery system
DE19940944B4 (de) 1999-08-31 2006-10-12 Grünenthal GmbH Retardierte, orale, pharmazeutische Darreichungsformen
CA2408956C (en) * 2000-05-18 2011-07-12 Therics, Inc. Method and form of a drug delivery device,such as encapsulating a toxic core within a non-toxic region in an oral dosage form
MXPA03008057A (es) 2001-03-05 2004-10-15 Johnson & Johnson Composiciones farmaceuticas con sabor oculto.
US7931914B2 (en) * 2001-10-29 2011-04-26 Massachusetts Institute Of Technology System and method for uniaxial compression of an article, such as a three-dimensionally printed dosage form
WO2003041690A2 (en) * 2001-10-29 2003-05-22 Therics, Inc. Three-dimensional suspension printing of dosage forms
AU2002302890A1 (en) * 2002-02-04 2003-12-02 Ranbaxy Laboratories Limited Hydrodynamically balancing oral drug delivery system with biphasic release
FR2838647B1 (fr) 2002-04-23 2006-02-17 Particules enrobees a liberation prolongee, leur procede de preparation et comprimes les contenant
WO2004022037A1 (en) * 2002-09-04 2004-03-18 Ranbaxy Laboratories Limited Taste masked dosage forms and processes for their preparation
WO2004052345A1 (en) 2002-12-11 2004-06-24 Ranbaxy Laboratories Limited Coating composition for taste masking coating and methods for their application and use
CA2524806C (en) 2003-05-07 2011-07-12 Akina, Inc. Highly plastic granules for making fast melting tablets
FR2858556B1 (fr) 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
BRPI0413881A (pt) 2003-08-28 2006-10-24 Sandoz Ag composição farmacêutica compreendendo anticonvulsivante com revestimento de mascaramento de gosto
EP1701707A2 (en) 2003-12-29 2006-09-20 Alza Corporation, Inc. Drug granule coatings that impart smear resistance during mechanical compression
JP2008507508A (ja) * 2004-07-22 2008-03-13 株式會社アモーレパシフィック トピラメート徐放性製剤及びその製造方法
US20060127479A1 (en) 2004-10-08 2006-06-15 Natrajan Kumaraperumal Solvent free taste masked pharmaceutical compositions
US20060182796A1 (en) 2005-02-03 2006-08-17 Abrika Pharmaceuticals, Inc. Taste masked pharmaceutical compositions
US20070092553A1 (en) 2005-10-21 2007-04-26 Pfab Lp Compositions and methods of making rapidly dissolving lonically masked formulations
US9744137B2 (en) * 2006-08-31 2017-08-29 Supernus Pharmaceuticals, Inc. Topiramate compositions and methods of enhancing its bioavailability
CN102218044A (zh) * 2006-12-04 2011-10-19 苏佩努斯制药公司 托吡酯的增强的立即释放制剂
BRPI0819231B8 (pt) * 2007-10-31 2021-05-25 Mcneil Ppc Inc processo para preparo de forma farmacêutica de desintegração rápida por moldagem a quente na presença de sal inorgânico hidratado
WO2009106824A2 (en) * 2008-02-25 2009-09-03 Cipla Limited Pharmaceutical formulations
EP2397161B1 (en) 2009-02-12 2019-09-25 Fuji Chemical Industry Co., Ltd. Disintegrating particle composition and rapidly disintegrating compression-molded material comprising same
US20100285130A1 (en) 2009-05-06 2010-11-11 Monosol Rx, Llc Coating of complexed actives in film formulations
US20120076858A1 (en) 2009-06-04 2012-03-29 Basf Se Orally Disintegrating Dosage Forms Containing Taste-Masked Active Ingredients
EP2467126A1 (en) * 2009-08-19 2012-06-27 Bayer Pharma Aktiengesellschaft Drug delivery systems (wafer) for pediatric use
AR079862A1 (es) * 2010-01-08 2012-02-22 Eurand Inc Composicion de topiramato con sabor enmascarado, un comprimido desintegrable oralmente que comprende la misma y metodo de preparacion
JP6133009B2 (ja) * 2010-08-11 2017-05-24 協和発酵キリン株式会社 トピラマート顆粒
US9381154B2 (en) * 2011-06-09 2016-07-05 Xerox Corporation Direct inkjet fabrication of drug delivery devices

Similar Documents

Publication Publication Date Title
JP2016514686A5 (OSRAM)
JP2016513724A5 (OSRAM)
ES2761407T3 (es) Forma de dosificación rápidamente dispersable de topiramato
JP6040218B2 (ja) 口腔内崩壊錠用直打賦形剤及びその製造方法、並びに口腔内崩壊錠
ES2244167T3 (es) Nuevas preparaciones farmaceuticas multiunitarias estables que contienen bencimidazoles sustituidos.
JP2018162276A5 (OSRAM)
JP2009512663A5 (OSRAM)
JP2016514680A5 (OSRAM)
Kumar et al. Impact of spray drying over conventional surface adsorption technique for improvement in micromeritic and biopharmaceutical characteristics of self-nanoemulsifying powder loaded with two lipophilic as well as gastrointestinal labile drugs
JP2018517735A5 (OSRAM)
JP5761018B2 (ja) 被覆固形製剤
KR20050040869A (ko) 친유성 활성 성분을 함유하는 고형 약학적 조성물 및 그제조방법
JP2013540148A (ja) 多粒子状の胃保持型製剤の製造方法
JP2016508502A5 (OSRAM)
JPWO2019132006A1 (ja) コーテッドサンド及びその製造方法並びに鋳型の製造方法
JP2015533164A5 (OSRAM)
JP5160423B2 (ja) 水易溶性薬物含有球状素顆粒の製造方法
CN108633256A (zh) 含水胶囊、以及含水胶囊的制造方法
Li et al. Preparation and evaluation of nano-hydroxyapatite/poly (styrene-divinylbenzene) porous microsphere for aspirin carrier
JP6042084B2 (ja) 液状組成物、及びこれを含有する軟カプセル剤
JP6027911B2 (ja) 賦形剤造粒物及びその製造方法、並びに錠剤
JP5454162B2 (ja) フィルムコーティングされた昇華性成分含有固形製剤
WO2015198483A1 (ja) 賦形剤造粒物、及び錠剤
JP2011046750A (ja) 口腔内速崩壊性錠
US20040170686A1 (en) Suspension vehicle for coated drug particles